# Mangoceuticals, Inc.: Form 8-K, filed Dec 10, 2025

- Company: [Mangoceuticals, Inc.](/companies/mgrx.md) (CIK 1938046)
- Form: 8-K
- Filed: 2025-12-10
- Accepted by EDGAR: Dec 10, 2025, 06:40 ET
- Period: 2025-12-04
- Accession: 0001493152-25-027009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225027009/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1938046/000149315225027009/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1938046/000149315225027009/form8-k.htm

Filed Dec 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001493152-25-027009. Last ingested by Listed: Nov 6, 2026, 18:28 ET. No prices; not investment advice.